Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, October 2017. Similar data can be found here: http://www.wcisu.wales.nhs.uk.

About this data

Penile cancer incidence is strongly related to age, with the highest incidence rates being in older men. In the UK in 2013-2015, on average each year around a third (32%) of new cases were in males aged 75 and over.[1-4]

Age-specific incidence rates rise steadily from around age 35-39. The highest rates are in the 90+ age group.

Penile Cancer (C60), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Population, Males, UK, 2013-2015

95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS Rate

For penile cancer, like most cancer types, incidence increases with age. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, October 2017. Similar data can be found here: http://www.wcisu.wales.nhs.uk.

Penile cancer incidence rates have remained stable overall in some broad adult age groups in males in the UK since the early 1990s, but increased in some.[1-4] Rates in 25-49s have remained stable, in 50-59s have increased by 47%, in 60-69s have increased by 75%, in 70-79s have remained stable, and in 80+s have remained stable.

For penile cancer, like most cancer types, incidence trends largely reflect changing prevalence of risk factors and improvements in diagnosis and data recording. Recent incidence trends are influenced by risk factor prevalence in years past, and trends by age group reflect risk factor exposure in birth cohorts.

Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, October 2017. Similar data can be found here: http://www.wcisu.wales.nhs.uk.

About this data

The lifetime risk of developing penile cancer is around 1 in 585 for men, in 2012 in the UK.[1]

The lifetime risk for penile cancer has been calculated on the assumption that the possibility of having more than one diagnosis of penile cancer over the course of a lifetime is very low (‘Current Probability’ method).[2]

See also

References

Lifetime risk estimates calculated by the Statistical Information Team at Cancer Research UK. Based on data provided by the Office of National Statistics, ISD Scotland, the Welsh Cancer Intelligence and Surveillance Unit and the Northern Ireland Cancer Registry, on request, December 2013 to July 2014.

There is evidence for an association between penile cancer incidence and deprivation in England.[1] England-wide data for 2006-2010 show European age-standardised incidence rates are 59% higher for males living in the most deprived areas compared with the least deprived.[1]

The estimated deprivation gradient in penile cancer incidence between males living in the most and least deprived areas in England has not changed in the period 1996-2010.[1] It has been estimated that there would have been around 70 fewer cancer cases each year in England during 2006-2010 if all males experienced the same incidence rates as the least deprived.[1]

References

About this data

Data is for UK, 2006-2010, ICD-10 C60

Deprivation gradient statistics were calculated using incidence data for 2006-2010. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.Graphics (when reused unaltered): Credit: Cancer Research UK.Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Follow us

Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666) and the Isle of Man (1103). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: Angel Building, 407 St John Street, London EC1V 4AD.